<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31924205</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>Cellular receptors for enterovirus A71.</ArticleTitle><Pagination><StartPage>23</StartPage><MedlinePgn>23</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-020-0615-9</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) is one of the major causative agents of hand, foot, and mouth disease. EV-A71 infection is sometimes associated with severe neurological diseases such as acute encephalitis, acute flaccid paralysis, and cardiopulmonary failure. Therefore, EV-A71 is a serious public health concern. Scavenger receptor class B, member 2 (SCARB2) is a type III transmembrane protein that belongs to the CD36 family and is a major receptor for EV-A71. SCARB2 supports attachment and internalization of the virus and initiates conformational changes that lead to uncoating of viral RNA in the cytoplasm. The three-dimensional structure of the virus-receptor complex was elucidated by cryo-electron microscopy. Two &#x3b1;-helices in the head domain of SCARB2 bind to the G-H loop of VP1 and the E-F loop of VP2 capsid proteins of EV-A71. Uncoating takes place in a SCARB2- and low pH-dependent manner. In addition to SCARB2, other molecules support cell surface binding of EV-A71. Heparan sulfate proteoglycans, P-selectin glycoprotein ligand-1, sialylated glycan, annexin II, vimentin, fibronectin, and prohibitin enhance viral infection by retaining the virus on the cell surface. These molecules are known as "attachment receptors" because they cannot initiate uncoating. In vivo, SCARB2 expression was observed in EV-A71 antigen-positive neurons and epithelial cells in the crypts of the palatine tonsils in patients that died of EV-A71 infection. Adult mice are not susceptible to infection by EV-A71, but transgenic mice that express human SCARB2 become susceptible to EV-A71 infection and develop neurological diseases similar to those observed in humans. Attachment receptors may also be involved in EV-A71 infection in vivo. Although heparan sulfate proteoglycans are expressed by many cultured cell lines and enhance infection by a subset of EV-A71 strains, they are not expressed by cells that express SCARB2 at high levels in vivo. Thus, heparan sulfate-positive cells merely adsorb the virus and do not contribute to replication or dissemination of the virus in vivo. In addition to these attachment receptors, cyclophilin A and human tryptophanyl aminoacyl-tRNA synthetase act as an uncoating regulator and an entry mediator that can confer susceptibility to non-susceptibile cells in the absence of SCARB2, respectively. The roles of attachment receptors and other molecules in EV-A71 pathogenesis remain to be elucidated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Kyousuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. koike-st@igakuken.or.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP18H02667</GrantID><Agency>JPSP</Agency><Country/></Grant><Grant><GrantID>19fk0108084h1101</GrantID><Agency>AMED</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072756" MajorTopicYN="N">Protein Conformation, alpha-Helical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="Y">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Hand, foot, and mouth disease</Keyword><Keyword MajorTopicYN="N">Neurological disease</Keyword><Keyword MajorTopicYN="N">Uncoating, SCARB2</Keyword><Keyword MajorTopicYN="N">Viral receptor, attachment</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31924205</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pii">10.1186/s12929-020-0615-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pallansch M, Oberste MS, Whitton JL. Enteroviruses: polioviruses, Coxackieviruses, echoviruses, and newer enteroviruses. In: Knipe D, Howley PM, editors. Fields Virology. 6. Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; 2013. pp. 490&#x2013;530.</Citation></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterback R, Vuorinen T, Linna M, Susi P, Hyypia T, Waris M. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis. 2009;15(9):1485&#x2013;1488. doi: 10.3201/eid1509.090438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1509.090438</ArticleId><ArticleId IdType="pmc">PMC2819858</ArticleId><ArticleId IdType="pubmed">19788821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus epidemic working group. N Engl J Med. 1999;341(13):929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129(3):304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov KM, Lavrova IK, Martianova LI, Korolev MB, Bashkirtsev VN, Voroshilova MK. Investigation of physicochemical properties of Bulgarian strain 258 of enterovirus type 71. Brief report. Arch Virol. 1979;60(3&#x2013;4):359&#x2013;362. doi: 10.1007/BF01317508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317508</ArticleId><ArticleId IdType="pubmed">228641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60(3&#x2013;4):329&#x2013;340. doi: 10.1007/BF01317504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick JL. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis. 1984;6(Suppl 2):S387&#x2013;S390. doi: 10.1093/clinids/6.Supplement_2.S387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/6.Supplement_2.S387</ArticleId><ArticleId IdType="pubmed">6330839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the outbreak study group. Clin Infect Dis. 2000;31(3):678&#x2013;683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75(16):7732&#x2013;7738. doi: 10.1128/JVI.75.16.7732-7738.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.16.7732-7738.2001</ArticleId><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol. 1999;20(1):17&#x2013;23. doi: 10.1016/S0887-8994(98)00087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(98)00087-3</ArticleId><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, et al. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 2002;46(9):621&#x2013;627. doi: 10.1111/j.1348-0421.2002.tb02743.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02743.x</ArticleId><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, Su IJ. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol. 2002;40(1):10&#x2013;15. doi: 10.1128/JCM.40.1.10-15.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.1.10-15.2002</ArticleId><ArticleId IdType="pmc">PMC120096</ArticleId><ArticleId IdType="pubmed">11773085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad K. Hand, foot, and mouth disease outbreak reported in Singapore. Lancet. 2000;356(9238):1338. doi: 10.1016/S0140-6736(05)74253-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)74253-7</ArticleId><ArticleId IdType="pubmed">11073035</ArticleId></ArticleIdList></Reference><Reference><Citation>De W, Changwen K, Wei L, Monagin C, Jin Y, Cong M, et al. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch Virol. 2011;156(6):945&#x2013;953. doi: 10.1007/s00705-011-0929-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-0929-8</ArticleId><ArticleId IdType="pubmed">21305327</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CC, Lau SK, Woo PC, Yuen KY. Human enterovirus 71 epidemics: what's next? Emerg Health Threats J. 2013;6:19780. doi: 10.3402/ehtj.v6i0.19780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/ehtj.v6i0.19780</ArticleId><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM. Receptors. In: Ehrenfeld E, Domingo E, Roos RP, editors. The Picornaviruses. Washington, DC: ASM press; 2010. p. 73&#x2013;86.</Citation></Reference><Reference><Citation>Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol. 2004;85(Pt 10):2981&#x2013;2989. doi: 10.1099/vir.0.79883-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79883-0</ArticleId><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, Suzaki Y, et al. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol. 2002;67(2):207&#x2013;216. doi: 10.1002/jmv.2209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2209</ArticleId><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhongping X, Hua L, Ting Y, Zhengling L, Min F, Tianhong X, et al. Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys. Virus Res. 2016;213:82&#x2013;89. doi: 10.1016/j.virusres.2015.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.11.007</ArticleId><ArticleId IdType="pubmed">26555165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Cui W, Liu L, Wang J, Zhao H, Liao Y, et al. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab Invest J Tech Methods Pathol. 2011;91(9):1337&#x2013;1350. doi: 10.1038/labinvest.2011.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2011.82</ArticleId><ArticleId IdType="pubmed">21555996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC. The molecular basis of mouse adaptation by human enterovirus 71. J Gen Virol. 2008;89(Pt 7):1622&#x2013;1632. doi: 10.1099/vir.0.83676-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Duo J, Liu J, Ma C, Zhang L, Wei Q, et al. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect/ Institut Pasteur. 2011;13(10):862&#x2013;870. doi: 10.1016/j.micinf.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.04.004</ArticleId><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78(15):7916&#x2013;7924. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Wang YF, Yu CK, Su IJ, Wang JR. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology. 2012;422(1):132&#x2013;143. doi: 10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh MT, Wang SW, Yu CK, Lin KH, Lei HY, Su IJ, et al. A single nucleotide in stem loop II of 5&#x2032;-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS One. 2011;6(11):e27082. doi: 10.1371/journal.pone.0027082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027082</ArticleId><ArticleId IdType="pmc">PMC3206083</ArticleId><ArticleId IdType="pubmed">22069490</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012;86(10):5686&#x2013;5696. doi: 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J, van den Hengel LG, Raaben M, Blomen VA, Carette JE, Brummelkamp TR. KREMEN1 is a host entry receptor for a major Group of Enteroviruses. Cell Host Microbe. 2018;23(5):636&#x2013;643. doi: 10.1016/j.chom.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.03.019</ArticleId><ArticleId IdType="pubmed">29681460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 1989;56(5):855&#x2013;865. doi: 10.1016/0092-8674(89)90690-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90690-9</ArticleId><ArticleId IdType="pubmed">2538245</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, et al. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 1990;9(10):3217&#x2013;3224. doi: 10.1002/j.1460-2075.1990.tb07520.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1990.tb07520.x</ArticleId><ArticleId IdType="pmc">PMC552052</ArticleId><ArticleId IdType="pubmed">2170108</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, et al. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A. 1991;88(3):951&#x2013;955. doi: 10.1073/pnas.88.3.951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.3.951</ArticleId><ArticleId IdType="pmc">PMC50932</ArticleId><ArticleId IdType="pubmed">1846972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren RB, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 1990;63(2):353&#x2013;362. doi: 10.1016/0092-8674(90)90168-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(90)90168-E</ArticleId><ArticleId IdType="pubmed">2170026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79(7):4460&#x2013;4469. doi: 10.1128/JVI.79.7.4460-4469.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe Y, Fujii K, Nagata N, Takeuchi O, Akira S, Oshiumi H, et al. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J Virol. 2012;86(1):185&#x2013;194. doi: 10.1128/JVI.05245-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05245-11</ArticleId><ArticleId IdType="pmc">PMC3255933</ArticleId><ArticleId IdType="pubmed">22072781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of Enterovirus 71 and enhances viral infectivity. J Virol. 2011;85(22):11809&#x2013;11820. doi: 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H, Zhang H, Zhang W, Song L, et al. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol. 2014;88(10):5816&#x2013;5833. doi: 10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Wang YF, Huang SW, Lo YC, Wang YH, Wu SR, et al. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol. 2015;89(8):4527&#x2013;4538. doi: 10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol. 2013;87(1):611&#x2013;620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009;6:141. doi: 10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>He QQ, Ren S, Xia ZC, Cheng ZK, Peng NF, Zhu Y. Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry. J Virol. 2018;92(9):e02251-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference><Reference><Citation>Too IHK, Bonne I, Tan EL, Chu JJH, Alonso S. Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis. PLoS Pathog. 2018;14(1):e1006778. doi: 10.1371/journal.ppat.1006778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006778</ArticleId><ArticleId IdType="pmc">PMC5764453</ArticleId><ArticleId IdType="pubmed">29324904</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, et al. Cyclophilin a associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog. 2014;10(10):e1004422. doi: 10.1371/journal.ppat.1004422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung ML, Jia L, Yip CCY, Chan JFW, Teng JLL, Chan KH, et al. Human tryptophanyl-tRNA synthetase is an IFN-gamma-inducible entry factor for Enterovirus. J Clin Invest. 2018;128(11):5163&#x2013;5177. doi: 10.1172/JCI99411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99411</ArticleId><ArticleId IdType="pmc">PMC6205371</ArticleId><ArticleId IdType="pubmed">30153112</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo D, Dopazo J, Vega MA. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. Genomics. 1995;25(1):100&#x2013;106. doi: 10.1016/0888-7543(95)80114-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0888-7543(95)80114-2</ArticleId><ArticleId IdType="pubmed">7539776</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13(3):137&#x2013;145. doi: 10.1016/S0962-8924(03)00005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(03)00005-9</ArticleId><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 2002;115(Pt 21):4117&#x2013;4131. doi: 10.1242/jcs.00075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.00075</ArticleId><ArticleId IdType="pubmed">12356916</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanz J, Groth J, Zachos C, Wehling C, Saftig P, Schwake M. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. Hum Mol Genet. 2010;19(4):563&#x2013;572. doi: 10.1093/hmg/ddp523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp523</ArticleId><ArticleId IdType="pubmed">19933215</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, et al. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007;131(4):770&#x2013;783. doi: 10.1016/j.cell.2007.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.018</ArticleId><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference><Reference><Citation>Neculai D, Schwake M, Ravichandran M, Zunke F, Collins RF, Peters J, et al. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature. 2013;504:172&#x2013;176. doi: 10.1038/nature12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12684</ArticleId><ArticleId IdType="pubmed">24162852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, Wang X, Wang Q, Wang Y, Lin J, Sun Y, et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5(9):692&#x2013;703. doi: 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Ren J, Padilla-Parra S, Fry EE, Stuart DI. Lysosome sorting of beta-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor. Nat Commun. 2014;5:4321. doi: 10.1038/ncomms5321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5321</ArticleId><ArticleId IdType="pmc">PMC4104448</ArticleId><ArticleId IdType="pubmed">25027712</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol. 2011;85(10):4937&#x2013;4946. doi: 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhao Y, Kotecha A, Fry EE, Kelly JT, Wang X, et al. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol. 2019;4(3):414&#x2013;419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013;87(6):3335&#x2013;3347. doi: 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson NH, Kolatkar PR, Oliveira MA, Cheng RH, Greve JM, McClelland A, et al. Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A. 1993;90(2):507&#x2013;511. doi: 10.1073/pnas.90.2.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.2.507</ArticleId><ArticleId IdType="pmc">PMC45692</ArticleId><ArticleId IdType="pubmed">8093643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolatkar PR, Bella J, Olson NH, Bator CM, Baker TS, Rossmann MG. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J. 1999;18(22):6249&#x2013;6259. doi: 10.1093/emboj/18.22.6249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.22.6249</ArticleId><ArticleId IdType="pmc">PMC1171688</ArticleId><ArticleId IdType="pubmed">10562537</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Bowman VD, Mueller S, Bator CM, Bella J, Peng X, et al. Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A. 2000;97(1):79&#x2013;84. doi: 10.1073/pnas.97.1.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.1.79</ArticleId><ArticleId IdType="pmc">PMC26619</ArticleId><ArticleId IdType="pubmed">10618374</ArticleId></ArticleIdList></Reference><Reference><Citation>Belnap DM, McDermott BM, Jr, Filman DJ, Cheng N, Trus BL, Zuccola HJ, et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A. 2000;97(1):73&#x2013;78. doi: 10.1073/pnas.97.1.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.1.73</ArticleId><ArticleId IdType="pmc">PMC26618</ArticleId><ArticleId IdType="pubmed">10618373</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol. 2001;8(10):874&#x2013;878. doi: 10.1038/nsb1001-874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb1001-874</ArticleId><ArticleId IdType="pmc">PMC4152846</ArticleId><ArticleId IdType="pubmed">11573093</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A. 2013;110(36):14753&#x2013;14758. doi: 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Ong KC, Gao Z, Zhao X, Anderson VM, McNutt MA, et al. Tonsillar crypt epithelium is an important extra-central nervous system site for viral replication in EV71 encephalomyelitis. Am J Pathol. 2014;184(3):714&#x2013;720. doi: 10.1016/j.ajpath.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.11.009</ArticleId><ArticleId IdType="pubmed">24378407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, Liang CT, Jiang ST, Chen KH, Yang CC, Cheng ML, et al. A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71. J Virol. 2019;93(11):e00183-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532076</ArticleId><ArticleId IdType="pubmed">30894476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One. 2013;8(2):e57591. doi: 10.1371/journal.pone.0057591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Liu Q, Wu X, Chen P, Wu X, Guo Y, et al. A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice. Vaccine. 2016;34(24):2729&#x2013;2736. doi: 10.1016/j.vaccine.2016.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.04.029</ArticleId><ArticleId IdType="pubmed">27102822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Chen N, Zhou S, Zheng K, Sun L, Zhang Y, et al. Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route. Emerg Microbes Infect. 2018;7(1):205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6281673</ArticleId><ArticleId IdType="pubmed">30518755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M, Iwasaki T, Taya C, Sato Y, Li J, Nagata N, et al. Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns. J Gen Virol. 2002;83(Pt 5):1095&#x2013;1105. doi: 10.1099/0022-1317-83-5-1095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-5-1095</ArticleId><ArticleId IdType="pubmed">11961264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem. 1991;60:443&#x2013;475. doi: 10.1146/annurev.bi.60.070191.002303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.60.070191.002303</ArticleId><ArticleId IdType="pubmed">1883201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin S., Lamanna W. C., Esko J. D. Heparan Sulfate Proteoglycans. Cold Spring Harbor Perspectives in Biology. 2011;3(7):a004952&#x2013;a004952. doi: 10.1101/cshperspect.a004952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004952</ArticleId><ArticleId IdType="pmc">PMC3119907</ArticleId><ArticleId IdType="pubmed">21690215</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997;3(8):866&#x2013;871. doi: 10.1038/nm0897-866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0897-866</ArticleId><ArticleId IdType="pubmed">9256277</ArticleId></ArticleIdList></Reference><Reference><Citation>Trybala E, Liljeqvist JA, Svennerholm B, Bergstrom T. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol. 2000;74(19):9106&#x2013;9114. doi: 10.1128/JVI.74.19.9106-9114.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.9106-9114.2000</ArticleId><ArticleId IdType="pmc">PMC102109</ArticleId><ArticleId IdType="pubmed">10982357</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M, Yanagishita M, Roderiquez G, Bou-Habib DC, Oravecz T, Hascall VC, et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses. 1993;9(2):167&#x2013;174. doi: 10.1089/aid.1993.9.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.1993.9.167</ArticleId><ArticleId IdType="pubmed">8096145</ArticleId></ArticleIdList></Reference><Reference><Citation>Trybala E, Bergstrom T, Spillmann D, Svennerholm B, Olofsson S, Flynn SJ, et al. Mode of interaction between pseudorabies virus and heparan sulfate/heparin. Virology. 1996;218(1):35&#x2013;42. doi: 10.1006/viro.1996.0163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0163</ArticleId><ArticleId IdType="pubmed">8615039</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes AP, Griffin DE. Binding of Sindbis virus to cell surface heparan sulfate. J Virol. 1998;72(9):7349&#x2013;7356. doi: 10.1128/JVI.72.9.7349-7356.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.9.7349-7356.1998</ArticleId><ArticleId IdType="pmc">PMC109959</ArticleId><ArticleId IdType="pubmed">9696831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CS, Hsiao JC, Chang YS, Chang W. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol. 1998;72(2):1577&#x2013;1585. doi: 10.1128/JVI.72.2.1577-1585.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.2.1577-1585.1998</ArticleId><ArticleId IdType="pmc">PMC124638</ArticleId><ArticleId IdType="pubmed">9445060</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow IG, Sioofy AB, Powell RM, Evans DJ. Echoviruses bind heparan sulfate at the cell surface. J Virol. 2001;75(10):4918&#x2013;4921. doi: 10.1128/JVI.75.10.4918-4921.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.10.4918-4921.2001</ArticleId><ArticleId IdType="pmc">PMC114248</ArticleId><ArticleId IdType="pubmed">11312365</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeish NJ, Williams CH, Kaloudas D, Roivainen MM, Stanway G. Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J Virol. 2012;86(20):11163&#x2013;11170. doi: 10.1128/JVI.00640-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00640-12</ArticleId><ArticleId IdType="pmc">PMC3457184</ArticleId><ArticleId IdType="pubmed">22855495</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, et al. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol. 1996;70(8):5282&#x2013;5287. doi: 10.1128/JVI.70.8.5282-5287.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.70.8.5282-5287.1996</ArticleId><ArticleId IdType="pmc">PMC190485</ArticleId><ArticleId IdType="pubmed">8764038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2017;501:79&#x2013;87. doi: 10.1016/j.virol.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, et al. Mutations in VP1 and 5&#x2032;-UTR affect enterovirus 71 virulence. Sci Rep. 2018;8(1):6688. doi: 10.1038/s41598-018-25091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25091-7</ArticleId><ArticleId IdType="pmc">PMC5923339</ArticleId><ArticleId IdType="pubmed">29703921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Sudaka Y, Takashino A, Imura A, Fujii K, Koike S. Amino acid variation at VP1-145 of Enterovirus 71 determines attachment receptor usage and Neurovirulence in human scavenger receptor B2 transgenic mice. J Virol. 2018;92(15):e00681-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Sudaka Y, Takashino A, Kobayashi K, Kataoka C, Suzuki T, et al. VP1 amino acid residue 145 of Enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during Cynomolgus monkey infection. J Virol. 2018;92(15):e00682-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee HK, Tan CW, Yogarajah T, Lee MHP, Chai HJ, Hanapi NA, et al. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive EV-A71 virulence in mice. PLoS Pathog. 2019;15(11):e1007863. doi: 10.1371/journal.ppat.1007863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007863</ArticleId><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Hall RA, Lobigs M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol. 2004;78(15):8271&#x2013;8280. doi: 10.1128/JVI.78.15.8271-8280.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8271-8280.2004</ArticleId><ArticleId IdType="pmc">PMC446099</ArticleId><ArticleId IdType="pubmed">15254199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Lobigs M. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol. 2002;76(10):4901&#x2013;4911. doi: 10.1128/JVI.76.10.4901-4911.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.10.4901-4911.2002</ArticleId><ArticleId IdType="pmc">PMC136177</ArticleId><ArticleId IdType="pubmed">11967307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Wright PJ, Davidson A, Lobigs M. Virulence attenuation of dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. J Gen Virol. 2006;87(Pt 10):2791&#x2013;2801. doi: 10.1099/vir.0.82164-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82164-0</ArticleId><ArticleId IdType="pubmed">16963737</ArticleId></ArticleIdList></Reference><Reference><Citation>Anez G, Men R, Eckels KH, Lai CJ. Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques. J Virol. 2009;83(20):10384&#x2013;10394. doi: 10.1128/JVI.01083-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01083-09</ArticleId><ArticleId IdType="pmc">PMC2753127</ArticleId><ArticleId IdType="pubmed">19656873</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimstra WB, Ryman KD, Johnston RE. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol. 1998;72(9):7357&#x2013;7366. doi: 10.1128/JVI.72.9.7357-7366.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.9.7357-7366.1998</ArticleId><ArticleId IdType="pmc">PMC109960</ArticleId><ArticleId IdType="pubmed">9696832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard KA, Klimstra WB, Johnston RE. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology. 2000;276(1):93&#x2013;103. doi: 10.1006/viro.2000.0546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0546</ArticleId><ArticleId IdType="pubmed">11021998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl CW, Kroschewski H, Allison SL, Kofler R, Holzmann H, Meixner T, et al. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol. 2001;75(12):5627&#x2013;5637. doi: 10.1128/JVI.75.12.5627-5637.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.12.5627-5637.2001</ArticleId><ArticleId IdType="pmc">PMC114275</ArticleId><ArticleId IdType="pubmed">11356970</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner CL, Hritz J, Sun C, Vanlandingham DL, Song TY, Ghedin E, et al. Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis. 2014;8(2):e2719. doi: 10.1371/journal.pntd.0002719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002719</ArticleId><ArticleId IdType="pmc">PMC3930508</ArticleId><ArticleId IdType="pubmed">24587470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Watters K, Basnet S, Sijapati S, Hill M, Palmenberg AC, et al. Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells. Virology. 2016;499:350&#x2013;360. doi: 10.1016/j.virol.2016.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.09.025</ArticleId><ArticleId IdType="pmc">PMC5110265</ArticleId><ArticleId IdType="pubmed">27743961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasak M, Goesler I, Blaas D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol. 2005;79(10):5963&#x2013;5970. doi: 10.1128/JVI.79.10.5963-5970.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.10.5963-5970.2005</ArticleId><ArticleId IdType="pmc">PMC1091682</ArticleId><ArticleId IdType="pubmed">15857982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol. 1997;71(7):5115&#x2013;5123. doi: 10.1128/JVI.71.7.5115-5123.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.7.5115-5123.1997</ArticleId><ArticleId IdType="pmc">PMC191746</ArticleId><ArticleId IdType="pubmed">9188578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9(7):e1003511. doi: 10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Aoki Y, Suto A, Ootani K, Katsushima N, Itagaki T, et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine. 2009;27(24):3153&#x2013;3158. doi: 10.1016/j.vaccine.2009.03.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.060</ArticleId><ArticleId IdType="pubmed">19446185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, et al. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol. 2005;43(12):6171&#x2013;6175. doi: 10.1128/JCM.43.12.6171-6175.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.12.6171-6175.2005</ArticleId><ArticleId IdType="pmc">PMC1317214</ArticleId><ArticleId IdType="pubmed">16333123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, et al. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8(7):e1002826. doi: 10.1371/journal.ppat.1002826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka ED, Sobo K, Stoppini L, Cagno V, Abdul F, Piuz I, et al. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 2018;14(8):e1007190. doi: 10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 1996;88(8):3010&#x2013;3021. doi: 10.1182/blood.V88.8.3010.bloodjournal8883010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V88.8.3010.bloodjournal8883010</ArticleId><ArticleId IdType="pubmed">8874199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993;75(6):1179&#x2013;1186. doi: 10.1016/0092-8674(93)90327-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90327-M</ArticleId><ArticleId IdType="pubmed">7505206</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers WS, Tang J, Shaw GD, Camphausen RT. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103(3):467&#x2013;479. doi: 10.1016/S0092-8674(00)00138-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)00138-0</ArticleId><ArticleId IdType="pubmed">11081633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HY, Yang YT, Yu SL, Hsiao KN, Liu CC, Sia C, et al. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J Virol. 2013;87(16):9064&#x2013;9076. doi: 10.1128/JVI.00573-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K, Nishimura Y, Abo M, Wakita T, Shimizu H. Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol. 2011;92(Pt 2):287&#x2013;291. doi: 10.1099/vir.0.022418-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.022418-0</ArticleId><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6(11):e1001174. doi: 10.1371/journal.ppat.1001174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001174</ArticleId><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Dong W, Quan X, Ma C, Qin C, Zhang L. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol. 2012;157(3):539&#x2013;543. doi: 10.1007/s00705-011-1198-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1198-2</ArticleId><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C, Suzuki T, Kotani O, Iwata-Yoshikawa N, Nagata N, Ami Y, et al. The role of VP1 amino acid residue 145 of Enterovirus 71 in viral fitness and pathogenesis in a Cynomolgus monkey model. PLoS Pathog. 2015;11(7):e1005033. doi: 10.1371/journal.ppat.1005033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, McLaughlin NP, Pan J, Goldstein S, Hafenstein S, Shimizu H, et al. The Suramin derivative NF449 interacts with the 5-fold vertex of the Enterovirus A71 capsid to prevent virus attachment to PSGL-1 and Heparan sulfate. PLoS Pathog. 2015;11(10):e1005184. doi: 10.1371/journal.ppat.1005184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005184</ArticleId><ArticleId IdType="pmc">PMC4592248</ArticleId><ArticleId IdType="pubmed">26430888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Tijsma A, Mirabelli C, Baggen J, Wahedi M, Franco D, et al. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence. Emerg Microbes Infect. 2019;8(1):1076&#x2013;1085. doi: 10.1080/22221751.2019.1644142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1644142</ArticleId><ArticleId IdType="pmc">PMC6711088</ArticleId><ArticleId IdType="pubmed">31339457</ArticleId></ArticleIdList></Reference><Reference><Citation>Grindheim AK, Saraste J, Vedeler A. Protein phosphorylation and its role in the regulation of Annexin A2 function. Biochim Biophys Acta Gen Subj. 2017;1861(11 Pt A):2515&#x2013;2529. doi: 10.1016/j.bbagen.2017.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2017.08.024</ArticleId><ArticleId IdType="pubmed">28867585</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki NM, Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest J Tech Methods Pathol. 2007;87(9):851&#x2013;857. doi: 10.1038/labinvest.3700656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3700656</ArticleId><ArticleId IdType="pmc">PMC7100186</ArticleId><ArticleId IdType="pubmed">17632542</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajrishi MM, Tuteja R, Tuteja N. Nucleolin: the most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol. 2011;4(3):267&#x2013;275. doi: 10.4161/cib.4.3.14884.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.4.3.14884</ArticleId><ArticleId IdType="pmc">PMC3187884</ArticleId><ArticleId IdType="pubmed">21980556</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez Losada S, Canto-Nogues C, Munoz-Fernandez MA. A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol Dis. 2002;11(3):469&#x2013;478. doi: 10.1006/nbdi.2002.0566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0566</ArticleId><ArticleId IdType="pubmed">12586555</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med. 2011;17(9):1132&#x2013;1135. doi: 10.1038/nm.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2444</ArticleId><ArticleId IdType="pubmed">21841784</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman RD, Khuon S, Chou YH, Opal P, Steinert PM. The function of intermediate filaments in cell shape and cytoskeletal integrity. J Cell Biol. 1996;134(4):971&#x2013;983. doi: 10.1083/jcb.134.4.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.4.971</ArticleId><ArticleId IdType="pmc">PMC2120965</ArticleId><ArticleId IdType="pubmed">8769421</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Ravi V, Desai A. Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 2011;160(1&#x2013;2):404&#x2013;408. doi: 10.1016/j.virusres.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JK, Fahad AM, Shanmukhappa K, Kapil S. Defining the cellular target(s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J Virol. 2006;80(2):689&#x2013;696. doi: 10.1128/JVI.80.2.689-696.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.2.689-696.2006</ArticleId><ArticleId IdType="pmc">PMC1346842</ArticleId><ArticleId IdType="pubmed">16378972</ArticleId></ArticleIdList></Reference><Reference><Citation>Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog. 2009;5(5):e1000417. doi: 10.1371/journal.ppat.1000417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000417</ArticleId><ArticleId IdType="pmc">PMC2670497</ArticleId><ArticleId IdType="pubmed">19412526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WC, Fuller AO. Herpes simplex virus type 1 and pseudorabies virus bind to a common saturable receptor on Vero cells that is not heparan sulfate. J Virol. 1993;67(9):5088&#x2013;5097. doi: 10.1128/JVI.67.9.5088-5097.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.67.9.5088-5097.1993</ArticleId><ArticleId IdType="pmc">PMC237906</ArticleId><ArticleId IdType="pubmed">8394437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedellec P, Vicart P, Laurent-Winter C, Martinat C, Prevost MC, Brahic M. Interaction of Theiler's virus with intermediate filaments of infected cells. J Virol. 1998;72(12):9553&#x2013;9560. doi: 10.1128/JVI.72.12.9553-9560.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.12.9553-9560.1998</ArticleId><ArticleId IdType="pmc">PMC110461</ArticleId><ArticleId IdType="pubmed">9811688</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci. 2002;115(Pt 20):3861&#x2013;3863. doi: 10.1242/jcs.00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.00059</ArticleId><ArticleId IdType="pubmed">12244123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury I, Thompson WE, Thomas K. Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J Cell Physiol. 2014;229(8):998&#x2013;1004. doi: 10.1002/jcp.24531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24531</ArticleId><ArticleId IdType="pmc">PMC4413917</ArticleId><ArticleId IdType="pubmed">24347342</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194(3):209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Farmer JD, Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin a and FKBP-FK506 complexes. Cell. 1991;66(4):807&#x2013;815. doi: 10.1016/0092-8674(91)90124-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90124-H</ArticleId><ArticleId IdType="pubmed">1715244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Mei Q, Li J, He H. Cyclophilin a and viral infections. Biochem Biophys Res Commun. 2012;424(4):647&#x2013;650. doi: 10.1016/j.bbrc.2012.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.07.024</ArticleId><ArticleId IdType="pmc">PMC7092870</ArticleId><ArticleId IdType="pubmed">22814107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisselev LL. Mammalian tryptophanyl-tRNA synthetases. Biochimie. 1993;75(12):1027&#x2013;1039. doi: 10.1016/0300-9084(93)90002-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0300-9084(93)90002-A</ArticleId><ArticleId IdType="pubmed">7515282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>